Business description: QuidelOrtho Corporation

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Number of employees: 6,600

Sales by Activity: QuidelOrtho Corporation

Fiscal Period: December20202021202220232024

Diagnostic Kits / Equipment

1.66B 1.7B 3.27B 3B 2.78B
See all business segments

Geographical breakdown of sales: QuidelOrtho Corporation

Fiscal Period: December20202021202220232024

North America

- - 2.54B 1.88B 1.62B

Other

- - 303M 483M 502M

EMEA

- - 207M 327M 336M

China

- - 220M 310M 325M

Foreign

209M 283M - - -

United States

1.45B 1.42B - - -
See all geographic segments

Executive Committee: QuidelOrtho Corporation

Manager TitleAgeSince
Chief Executive Officer 60 05/05/2024
Director of Finance/CFO 58 -
Chief Operating Officer 56 14/11/2024
Chief Tech/Sci/R&D Officer - 06/10/2024
Chief Administrative Officer - 30/04/2022
See QUIDELORTHO CORPORATION governance

Composition of the Board of Directors: QuidelOrtho Corporation

Director TitleAgeSince
Chairman 71 10/12/2022
Director/Board Member 70 31/12/2021
Director/Board Member 81 31/12/1992
Director/Board Member 52 31/12/2017
Director/Board Member 72 31/12/2013
Director/Board Member 63 31/12/2020
Director/Board Member 67 31/12/2017
Director/Board Member 60 14/05/2024
Director/Board Member 61 05/12/2024
Director/Board Member 60 05/12/2024
Composition of the Board of Directors

Shareholders: QuidelOrtho Corporation

NameEquities%Valuation
T. Rowe Price Investment Management, Inc.
16.22 %
11,012,190 16.22 % 297 M $
BlackRock Advisors LLC
14.17 %
9,619,699 14.17 % 260 M $
Vanguard Fiduciary Trust Co.
11.25 %
7,636,193 11.25 % 206 M $
Rubric Capital Management LP
6.83 %
4,637,738 6.83 % 125 M $
Fidelity Management & Research Co. LLC
6.622 %
4,496,153 6.622 % 121 M $
List of QUIDELORTHO CORPORATION shareholders

Company details: QuidelOrtho Corporation

QuidelOrtho Corp.

9975 Summers Ridge Road

92121, San Diego

+858 552 1100

http://www.quidelortho.com
address QuidelOrtho Corporation(QDEL)

Group companies: QuidelOrtho Corporation

NameCategory and Sector
See all subsidiaries

Medical Diagnostic & Testing Equipment

Change 5d. change 1-year change 3-years change Capi.($)
-0.29%+0.99%-26.54%-70.49% 1.89B
-1.05%+1.35%+20.04%-30.82% 18.41B
+7.09%+4.73%+87.38%+266.46% 2.46B
-0.27%-2.53%+0.54%-1.24% 1.49B
+0.32%-4.27%-2.13%-16.08% 1.13B
+0.44%-5.02%+1.60%-42.79% 899M
+1.75%+1.49%+0.82%-24.43% 893M
+1.61%-0.67%-19.45%-46.86% 676M
-1.59%+45.52%+390.07% - 567M
+0.52%-0.07%-27.83%-43.79% 481M
Average +0.95%+1.98%+42.45%-1.11% 2.89B
Weighted average by Cap. -0.12%+3.21%+25.23%-6.31%
See all sector performances
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
27.82USD
Average target price
37.67USD
Spread / Average Target
+35.39%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. QDEL Stock
  4. Company QuidelOrtho Corporation